Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Adrenergic, alpha-2 | 6 | 2016 | 39 | 1.800 |
Why?
|
| Pain | 10 | 2023 | 290 | 1.380 |
Why?
|
| Estradiol | 6 | 2016 | 268 | 1.020 |
Why?
|
| Clonidine | 5 | 2016 | 50 | 0.980 |
Why?
|
| Pain Measurement | 11 | 2024 | 183 | 0.900 |
Why?
|
| Sex Characteristics | 6 | 2016 | 258 | 0.840 |
Why?
|
| Estrogens | 6 | 2016 | 203 | 0.770 |
Why?
|
| Analgesics | 3 | 2016 | 55 | 0.660 |
Why?
|
| Hyperalgesia | 2 | 2016 | 24 | 0.570 |
Why?
|
| Rats, Sprague-Dawley | 18 | 2018 | 1766 | 0.550 |
Why?
|
| Testosterone | 5 | 2016 | 211 | 0.540 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 98 | 0.500 |
Why?
|
| Nociceptors | 2 | 2006 | 30 | 0.470 |
Why?
|
| Peptide Fragments | 5 | 2003 | 307 | 0.450 |
Why?
|
| Ovariectomy | 9 | 2016 | 127 | 0.450 |
Why?
|
| Choline O-Acetyltransferase | 6 | 2003 | 36 | 0.440 |
Why?
|
| Serum Albumin, Bovine | 1 | 2014 | 49 | 0.410 |
Why?
|
| Cerebral Cortex | 4 | 2002 | 306 | 0.390 |
Why?
|
| Hippocampus | 5 | 2002 | 594 | 0.390 |
Why?
|
| Trigeminal Nuclei | 2 | 2009 | 11 | 0.370 |
Why?
|
| Rats | 16 | 2016 | 3735 | 0.370 |
Why?
|
| Aftercare | 2 | 2022 | 22 | 0.370 |
Why?
|
| Substance P | 3 | 2004 | 26 | 0.350 |
Why?
|
| Receptors, Opioid, kappa | 3 | 2018 | 23 | 0.350 |
Why?
|
| Spinal Cord | 5 | 2018 | 114 | 0.340 |
Why?
|
| Somatostatin | 4 | 2003 | 20 | 0.320 |
Why?
|
| Analgesics, Opioid | 3 | 2022 | 252 | 0.310 |
Why?
|
| Adrenergic alpha-Antagonists | 5 | 2009 | 29 | 0.290 |
Why?
|
| Microfilament Proteins | 1 | 2008 | 72 | 0.280 |
Why?
|
| Maze Learning | 6 | 2003 | 113 | 0.280 |
Why?
|
| Pentazocine | 2 | 2018 | 4 | 0.270 |
Why?
|
| Animals | 21 | 2018 | 16992 | 0.260 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 2006 | 6 | 0.250 |
Why?
|
| Hot Temperature | 5 | 2016 | 141 | 0.250 |
Why?
|
| Male | 22 | 2024 | 23409 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 386 | 0.240 |
Why?
|
| Cerebral Ventricles | 3 | 2001 | 23 | 0.230 |
Why?
|
| Pons | 1 | 2004 | 11 | 0.220 |
Why?
|
| Signal Transduction | 1 | 2014 | 2157 | 0.220 |
Why?
|
| N-Methylaspartate | 4 | 2009 | 59 | 0.210 |
Why?
|
| Female | 17 | 2024 | 24698 | 0.200 |
Why?
|
| Pain Threshold | 5 | 2023 | 34 | 0.190 |
Why?
|
| Social Class | 1 | 2024 | 291 | 0.180 |
Why?
|
| Receptors, Opioid | 3 | 2013 | 40 | 0.180 |
Why?
|
| Emergency Medical Services | 1 | 2022 | 79 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2014 | 1124 | 0.180 |
Why?
|
| Drug Interactions | 3 | 2014 | 150 | 0.170 |
Why?
|
| Parathion | 1 | 2001 | 3 | 0.170 |
Why?
|
| Reaction Time | 2 | 2014 | 157 | 0.170 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2001 | 44 | 0.170 |
Why?
|
| Neurotoxins | 1 | 2001 | 57 | 0.160 |
Why?
|
| Survivors | 1 | 2021 | 152 | 0.160 |
Why?
|
| Adrenergic alpha-Agonists | 3 | 2008 | 32 | 0.150 |
Why?
|
| Yohimbine | 3 | 2009 | 24 | 0.150 |
Why?
|
| Time Factors | 3 | 2014 | 1857 | 0.140 |
Why?
|
| Neuropeptide Y | 1 | 1998 | 25 | 0.140 |
Why?
|
| Neuropeptides | 1 | 1999 | 64 | 0.140 |
Why?
|
| Motor Activity | 1 | 2001 | 437 | 0.140 |
Why?
|
| Opioid Peptides | 2 | 2009 | 26 | 0.140 |
Why?
|
| Behavior, Animal | 4 | 2008 | 373 | 0.130 |
Why?
|
| Brain | 3 | 2003 | 1472 | 0.130 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 449 | 0.120 |
Why?
|
| Estrogen Antagonists | 1 | 2016 | 30 | 0.120 |
Why?
|
| Receptors, Opioid, mu | 1 | 2016 | 52 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 495 | 0.120 |
Why?
|
| Orchiectomy | 3 | 2010 | 37 | 0.110 |
Why?
|
| Aging | 1 | 2001 | 783 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 568 | 0.110 |
Why?
|
| Sex Factors | 2 | 2008 | 1028 | 0.100 |
Why?
|
| Cattle | 1 | 2014 | 498 | 0.090 |
Why?
|
| Receptors, Estrogen | 1 | 2013 | 183 | 0.090 |
Why?
|
| Young Adult | 4 | 2024 | 5080 | 0.090 |
Why?
|
| Adult | 6 | 2024 | 13872 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 458 | 0.090 |
Why?
|
| Adolescent | 4 | 2024 | 6081 | 0.090 |
Why?
|
| Patient Discharge | 2 | 2022 | 128 | 0.090 |
Why?
|
| Analgesia | 1 | 2010 | 11 | 0.080 |
Why?
|
| Testosterone Propionate | 1 | 2009 | 3 | 0.080 |
Why?
|
| Catheterization | 1 | 2009 | 22 | 0.080 |
Why?
|
| Infusions, Parenteral | 2 | 1999 | 13 | 0.080 |
Why?
|
| Hormone Replacement Therapy | 1 | 2009 | 49 | 0.080 |
Why?
|
| Brain Chemistry | 2 | 2001 | 141 | 0.080 |
Why?
|
| Arrestin | 1 | 2008 | 8 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2024 | 1600 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2010 | 575 | 0.070 |
Why?
|
| Alzheimer Disease | 3 | 2003 | 1001 | 0.070 |
Why?
|
| Humans | 8 | 2024 | 43102 | 0.060 |
Why?
|
| Catecholamines | 1 | 2006 | 45 | 0.060 |
Why?
|
| Synaptic Transmission | 1 | 2006 | 149 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2008 | 1035 | 0.060 |
Why?
|
| Dioxanes | 1 | 2004 | 11 | 0.060 |
Why?
|
| Retrospective Studies | 2 | 2022 | 2544 | 0.060 |
Why?
|
| Injections, Intraventricular | 2 | 2002 | 59 | 0.050 |
Why?
|
| Injections, Spinal | 2 | 2016 | 8 | 0.050 |
Why?
|
| Estrous Cycle | 2 | 2016 | 37 | 0.050 |
Why?
|
| Middle Aged | 3 | 2024 | 12222 | 0.050 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 135 | 0.050 |
Why?
|
| Ginkgo biloba | 1 | 2002 | 3 | 0.050 |
Why?
|
| Memory Disorders | 1 | 2002 | 77 | 0.050 |
Why?
|
| Prescriptions | 1 | 2021 | 19 | 0.050 |
Why?
|
| Melatonin | 1 | 2002 | 82 | 0.040 |
Why?
|
| Algorithms | 1 | 2024 | 509 | 0.040 |
Why?
|
| Trauma Centers | 1 | 2021 | 92 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2021 | 110 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 1067 | 0.040 |
Why?
|
| Entorhinal Cortex | 1 | 2001 | 11 | 0.040 |
Why?
|
| Mice | 3 | 2008 | 6644 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2021 | 142 | 0.040 |
Why?
|
| Acoustic Stimulation | 1 | 2001 | 78 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2024 | 1234 | 0.040 |
Why?
|
| Violence | 1 | 2021 | 136 | 0.040 |
Why?
|
| Infusion Pumps, Implantable | 1 | 1999 | 4 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 245 | 0.040 |
Why?
|
| Osmotic Pressure | 1 | 1999 | 22 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2003 | 561 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2010 | 95 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 1759 | 0.040 |
Why?
|
| Antioxidants | 1 | 2002 | 443 | 0.040 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 1998 | 7 | 0.040 |
Why?
|
| Ibotenic Acid | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cholinergic Agents | 1 | 1998 | 8 | 0.040 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 1998 | 7 | 0.040 |
Why?
|
| Cholinergic Fibers | 1 | 1998 | 12 | 0.040 |
Why?
|
| Immunotoxins | 1 | 1998 | 13 | 0.040 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 1998 | 43 | 0.040 |
Why?
|
| Mutation | 1 | 2003 | 1177 | 0.040 |
Why?
|
| Morphine | 1 | 2018 | 69 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2023 | 661 | 0.030 |
Why?
|
| Mass Screening | 1 | 2021 | 541 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 1998 | 306 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 590 | 0.030 |
Why?
|
| Child | 1 | 2022 | 3443 | 0.030 |
Why?
|
| Aged | 1 | 2024 | 8214 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 1997 | 1596 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2013 | 883 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 403 | 0.020 |
Why?
|
| 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer | 1 | 2010 | 4 | 0.020 |
Why?
|
| United States | 1 | 2022 | 5205 | 0.020 |
Why?
|
| Lumbosacral Region | 1 | 2010 | 14 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2010 | 14 | 0.020 |
Why?
|
| Naltrexone | 1 | 2010 | 34 | 0.020 |
Why?
|
| Mustard Plant | 1 | 2009 | 7 | 0.020 |
Why?
|
| Irritants | 1 | 2009 | 8 | 0.020 |
Why?
|
| Plant Oils | 1 | 2009 | 20 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 652 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2003 | 665 | 0.020 |
Why?
|
| Castration | 1 | 2008 | 34 | 0.020 |
Why?
|
| Narcotic Antagonists | 1 | 2006 | 78 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 758 | 0.010 |
Why?
|
| Presenilin-1 | 1 | 2003 | 28 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2002 | 60 | 0.010 |
Why?
|
| Memory | 1 | 2003 | 174 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2002 | 260 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 701 | 0.010 |
Why?
|
| Plant Extracts | 1 | 2002 | 302 | 0.010 |
Why?
|